Search

Your search keyword '"Moorman A. V."' showing total 1,040 results

Search Constraints

Start Over You searched for: Author "Moorman A. V." Remove constraint Author: "Moorman A. V."
1,040 results on '"Moorman A. V."'

Search Results

1. PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA

2. Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

9. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial

11. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia

12. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

13. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21

14. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia

15. Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial

16. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy

17. Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia

18. A dedicated caller for DUX4 rearrangements from whole-genome sequencing data.

19. Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

20. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial

21. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study

22. Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia

23. DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis

26. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study

27. Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL

28. IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial

29. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials

30. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group

31. Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study

33. A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia

34. Pelops: A dedicated caller for DUX4 rearrangements from whole-genome sequencing data

35. Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL

36. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.

38. Results from UKALL60+,:a phase 2 study in older patients with untreated acute lymphoblastic leukemia

40. Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL

41. Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations

43. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia

45. Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL

47. Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL

49. ETV6::RUNX1Acute Lymphoblastic Leukemia: how much therapy is needed for cure?

50. Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

Catalog

Books, media, physical & digital resources